Project Grant R21AI190872
Award Date
3/21/25
Completion Date
2/28/27
Dollars Obligated
$220K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This $870,800 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary purpose of this 2-year award, with a completion date of March 31, 2026, is to conduct innovative research to discriminate pathogenic from benign genetic variants of the DDX41 gene, which has been implicated in predisposing individuals to myelodysplastic syndrome (MDS) and acute myeloid...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $219,122 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Illinois to conduct research on novel sRNA-mediated regulation of Rho action in the 3' untranslated region (UTR) of HilD mRNA to affect mRNA stability in Salmonella Typhimurium. The project aims to understand the regulation of the identified sRNAs and their effects on the SPI1 regulatory system, which...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $649,053 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in Missouri. The grant will fund research to investigate the role of the Ly49 family of receptors on CD8 T cells, which have been shown to mark CD8 regulatory T cells (Tregs) in mice. The research aims to better understand the functional contribution of these Ly49 receptors to CD8 Tregs, as well...
This federal Project Grant award of $450,862.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to define the nature of the T cell receptor (TCR) repertoire expressed by naturally occurring IL-10-producing regulatory T (Tr1) cells in mice. The key objectives are to characterize the TCR diversity, antigen reactivity, differentiation, and transcriptional profiles of these Tr1 cells....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $374,064 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Los Angeles (UCLA) from July 1, 2024 to May 31, 2026. The purpose of this grant is to develop an in vivo T-cell therapy to treat HIV by delivering mRNA encoding T-cell receptors directly to T cells in the patient's blood and lymph system, using virus-like particles functionalized with...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $479,730 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin - Madison. The grant supports a 5-year research project to elucidate the mechanisms by which prophages (viral DNA integrated into bacterial genomes) modulate the production of the antimicrobial compound reuterin in the probiotic gut symbiont Limosilactobacilus reuteri. The research aims to...
The National Institute of Allergy and Infectious Diseases awarded a $443,175 Project Grant (R21AI184357) to the University of Wisconsin - Madison to conduct research on induced pluripotent stem cell (iPSC)-derived human neutrophils. The goal is to use single-cell multi-omics and in vivo zebrafish models to understand the heterogeneity and function of iPSC-derived neutrophils, as well as the effects of immune training on their antimicrobial properties. This research aims to develop a...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $1,019,807 Project Grant to the University of Missouri System on July 15, 2024. The grant's objective is to optimize Himar1 mutagenesis and expand targeted mutation capabilities in Ehrlichia chaffeensis and Anaplasma phagocytophilum, while also optimizing axenic media conditions to enable the continued replication of these tick-borne...
This $864,735 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify novel mechanisms for generating antiretroviral antibody responses. The award will fund studies to elucidate the genetic and immunologic basis of a TLR7-independent pathway for antibody production in response to retroviral infections, using murine models. The findings from this 2-year...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,787 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Stony Brook University. The project aims to track the secretion of proteins through the cell envelope of mycobacteria, including pathogens like Mycobacterium tuberculosis, to elucidate the mechanism of the ESX-1 secretion system. The research will utilize innovative approaches such as cell wall-specific protein tagging,...